At Sunovion, your impact will be felt near and far

You have the opportunity to be at the forefront of innovation. If you're curious, passionate and determined to make a difference, join us.

Sunovion Marlborough, MA, USA
May 08, 2019
This is a field-based position. The successful candidate will be a therapeutic expert with the purpose of advancing patient care and informing company medical strategies throughout the drug life cycle through scientific exchange with healthcare professionals, thought leaders and advocacy organizations. He or she will meet the scientific needs of the medical community on behalf of Sunovion by responding to unsolicited inquiries and facilitating scientific interactions with healthcare professionals and the medical community through the provision of disease state and product information. This includes developing and maintaining “peer to peer” scientific relationships with key thought leaders in health care, academia, and advocacy organizations. This individual will also contribute to the overall success of the Medical Science Liaison organization through involvement in internal initiatives aligned to medical objectives. Essential Functions • Identify national and regional thought leaders for a designated therapeutic area within a defined geography that may facilitate Sunovion’s medical efforts.  • Exchange information with the medical community on scientific issues, trends, ideas and practices related to patient care and identify unmet medical needs.  • Identify opportunities to work with the medical community; discuss research and medical information and facilitate initiation of clinical research studies, as appropriate.  • Develop and maintain a high level of therapeutic area, disease state and product expertise  • Attend regional and national professional medical and patient society meetings to learn, gather clinical and business insights and support corporate activities.  • Participate in training, and other internal efforts to support medical objectives.  • Appropriately document interactions and act in accordance with company policies and guidelines. Knowledge & skills (general and technical) Education level and/or relevant experience(s):  • PharmD, PhD, MD or DO (required). • Specialty training in psychiatry and certification preferred.  • Record of accomplishment in psychiatry related activities, preferably in Bipolar Disorder, ADHD, Binge Eating Disorder and/or Schizophrenia.  • 5-7 years of pharmaceutical industry experience (e.g., medical affairs, clinical development) with a minimum of 5 years’ experience as a medical liaison.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Fort Lee, NJ 07024, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Fort Lee, NJ 07024, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Fort Lee, NJ 07024, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Fort Lee, NJ 07024, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Fort Lee, NJ 07024, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.
Sunovion Marlborough, MA, USA
May 08, 2019
Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the  Be Vocal: Speak Up for Mental Health, COPD Together , and  Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting seven annual  Hands On!  days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.